Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma
Crossref DOI link: https://doi.org/10.1007/s00432-015-1963-9
Published Online: 2015-03-25
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herold, Michael
Scholz, Christian W.
Rothmann, Frank
Hirt, Carsten
Lakner, Volker
Naumann, Ralph
Text and Data Mining valid from 2015-03-25